Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial.

Vaughan K, McConaghy N.

Aust N Z J Psychiatry. 1999 Feb;33(1):84-8.

PMID:
10197889
3.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Woods SW, Gueorguieva RV, Baker CB, Makuch RW.

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. Review.

PMID:
16143728
4.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

5.

An orthomolecular approach to the prevention and treatment of psychiatric disorders.

Zell M, Grundmann O.

Adv Mind Body Med. 2012 Fall;26(2):14-28. Review.

PMID:
23341413
6.
7.

Megavitamins: fact and fancy.

Woolliscroft JO.

Dis Mon. 1983 Feb;29(5):1-56. Review. No abstract available.

PMID:
6337037
8.

Megavitamin therapy with pyridoxine.

Bässler KH.

Int J Vitam Nutr Res. 1988;58(1):105-18. Review. No abstract available.

PMID:
3290144
9.

Toxicity of vitamins: complications of a health movement.

Evans CD, Lacey JH.

Br Med J (Clin Res Ed). 1986 Feb 22;292(6519):509-10. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk